Search | Social.So

Rutuja Deshmukh added blog Other
2026-06-29 12:49:39 -

Real World Evidence Solutions Market Developments in Clinical and Post-Marketing Research
The global Real World Evidence (RWE) Solutions Market was valued at USD 3.0 billion in 2025 and is projected to grow from USD 3.3 billion in 2026 to USD 6.0 billion by 2033, registering a CAGR of 9.1% from 2026 to 2033. North America accounted for the largest revenue share of 44.1% in 2025, driven by increasing R&D investments, expanding applications of real-world evidence across...

0 Comments 0 Shares 58 Views 0 Reviews

Please log in to like, share and comment!
Rutuja Deshmukh added blog Other
2026-07-09 13:30:30 -

Clinical Trial Supplies Market Key Drivers and Restraints
The global Clinical Trial Supplies Market size was valued at USD 5.7 billion in 2025 and is projected to grow from USD 6.1 billion in 2026 to USD 10.7 billion by 2033, registering a CAGR of 8.4% from 2026 to 2033. North America accounted for the largest revenue share of 43.8% in 2025, supported by robust pharmaceutical research, strong biotechnology investments, advanced healthcare...

0 Comments 0 Shares 16 Views 0 Reviews

Please log in to like, share and comment!
Rutuja Deshmukh added blog Other
2026-07-02 07:38:47 -

Pharmaceutical CRO Market Opportunities in Emerging Economies
The global Pharmaceutical CRO Market size was valued at USD 45.3 billion in 2025 and is projected to grow from USD 48.5 billion in 2026 to USD 83.3 billion by 2033, expanding at a CAGR of 8.0% from 2026 to 2033. Asia Pacific accounted for the largest market share of 26.4% in 2025, driven by increasing clinical research activities, expanding pharmaceutical outsourcing, lower...

0 Comments 0 Shares 27 Views 0 Reviews

Please log in to like, share and comment!
Rutuja Deshmukh added blog Other
2026-07-03 07:23:31 -

qPCR Instruments Market Investment Opportunities and Forecast
The global qPCR Instruments Market size was valued at USD 1.1 billion in 2025 and is projected to grow from USD 1.2 billion in 2026 to USD 2.0 billion by 2033, registering a CAGR of 7.0% from 2026 to 2033. North America accounted for the largest revenue share of 40.9% in 2025, supported by advanced healthcare infrastructure, strong investments in molecular diagnostics, and widespread...

0 Comments 0 Shares 47 Views 0 Reviews

Please log in to like, share and comment!